Allison Bratzel
Stock Analyst at Piper Sandler
(4.92)
# 204
Out of 4,598 analysts
242
Total ratings
61.8%
Success rate
40.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Allison Bratzel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| REPL Replimune Group | Upgraded: Buy | $4 → $14 | $11.91 | +17.55% | 9 | Jul 31, 2026 | |
| ABCL AbCellera Biologics | Maintained: Buy | $17 → $12 | $5.83 | +105.83% | 6 | Jul 31, 2026 | |
| ABVX ABIVAX Société Anonyme | Rated: Buy | $165 → $175 | $124.78 | +40.25% | 13 | Jul 9, 2026 | |
| MGTX MeiraGTx Holdings | Maintained: Buy | $30 | $11.88 | +152.53% | 6 | Jul 8, 2026 | |
| HUMA Humacyte | Maintained: Hold | $1 | $0.6893 | +45.07% | 9 | Jun 18, 2026 | |
| INCY Incyte | Maintained: Buy | $110 | $118.43 | -7.12% | 12 | Jun 9, 2026 | |
| TVTX Travere Therapeutics | Maintained: Buy | $49 | $54.98 | -10.88% | 20 | Jun 3, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintained: Buy | $84 → $82 | $60.00 | +36.68% | 6 | May 21, 2026 | |
| RIGL Rigel Pharmaceuticals | Maintained: Hold | $40 | $37.43 | +6.87% | 9 | May 13, 2026 | |
| ARGX argenx SE | Maintained: Buy | $1,075 | $830.79 | +29.39% | 33 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $1.93 | +107.25% | 6 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $1.45 | +520.69% | 11 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $26 → $4 | $1.77 | +125.99% | 4 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $68 | $25.02 | +171.78% | 6 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $52 | $38.86 | +33.81% | 8 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $4.98 | +221.29% | 8 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $54.49 | +83.52% | 13 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $1.31 | +205.34% | 17 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $4.17 | +187.77% | 5 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $13.37 | +124.38% | 6 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 → $56 | $32.04 | +74.78% | 5 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 → $58 | $45.85 | +26.50% | 13 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 → $0.5 | $0.0002 | +249,900.00% | 5 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $33.32 | n/a | 6 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $8 → $20 | $8.02 | n/a | 6 | Mar 14, 2024 |
Replimune Group
Jul 31, 2026
Upgraded: Buy
Price Target: $4 → $14
Current: $11.91
Upside: +17.55%
AbCellera Biologics
Jul 31, 2026
Maintained: Buy
Price Target: $17 → $12
Current: $5.83
Upside: +105.83%
ABIVAX Société Anonyme
Jul 9, 2026
Rated: Buy
Price Target: $165 → $175
Current: $124.78
Upside: +40.25%
MeiraGTx Holdings
Jul 8, 2026
Maintained: Buy
Price Target: $30
Current: $11.88
Upside: +152.53%
Humacyte
Jun 18, 2026
Maintained: Hold
Price Target: $1
Current: $0.6893
Upside: +45.07%
Incyte
Jun 9, 2026
Maintained: Buy
Price Target: $110
Current: $118.43
Upside: -7.12%
Travere Therapeutics
Jun 3, 2026
Maintained: Buy
Price Target: $49
Current: $54.98
Upside: -10.88%
BioMarin Pharmaceutical
May 21, 2026
Maintained: Buy
Price Target: $84 → $82
Current: $60.00
Upside: +36.68%
Rigel Pharmaceuticals
May 13, 2026
Maintained: Hold
Price Target: $40
Current: $37.43
Upside: +6.87%
argenx SE
May 11, 2026
Maintained: Buy
Price Target: $1,075
Current: $830.79
Upside: +29.39%
May 11, 2026
Maintained: Buy
Price Target: $4
Current: $1.93
Upside: +107.25%
May 8, 2026
Maintained: Buy
Price Target: $9
Current: $1.45
Upside: +520.69%
May 8, 2026
Downgraded: Hold
Price Target: $26 → $4
Current: $1.77
Upside: +125.99%
May 7, 2026
Maintained: Buy
Price Target: $68
Current: $25.02
Upside: +171.78%
May 7, 2026
Maintained: Buy
Price Target: $52
Current: $38.86
Upside: +33.81%
May 1, 2026
Maintained: Buy
Price Target: $16
Current: $4.98
Upside: +221.29%
Apr 24, 2026
Maintained: Buy
Price Target: $100
Current: $54.49
Upside: +83.52%
Apr 24, 2026
Maintained: Buy
Price Target: $4
Current: $1.31
Upside: +205.34%
Apr 21, 2026
Maintained: Buy
Price Target: $12
Current: $4.17
Upside: +187.77%
Mar 24, 2026
Maintained: Buy
Price Target: $30
Current: $13.37
Upside: +124.38%
Mar 20, 2026
Maintained: Buy
Price Target: $42 → $56
Current: $32.04
Upside: +74.78%
Mar 4, 2026
Maintained: Buy
Price Target: $51 → $58
Current: $45.85
Upside: +26.50%
Jan 23, 2026
Downgraded: Hold
Price Target: $3 → $0.5
Current: $0.0002
Upside: +249,900.00%
Jul 18, 2024
Maintained: Buy
Price Target: $22
Current: $33.32
Upside: n/a
Mar 14, 2024
Upgraded: Buy
Price Target: $8 → $20
Current: $8.02
Upside: n/a